The Texas Cancer Registry (TCR) is a statewide, population-based registry that serves as the foundation for measuring the cancer burden in Texas, comprehensive cancer control efforts, health disparities, progress in prevention, diagnosis, treatment, and survivorship, and also supports a wide variety of cancer-related research. These priorities cannot be adequately addressed in public health, academic institutions, or the private sector without timely, complete, and accurate cancer data. The TCR is one of the largest cancer registries in the United States. It is one of twelve state registries funded by both the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) Program and Centers for Disease Control and Prevention’s National Program of Cancer Registries (NPCR). In addition to Texas, the other state registries supported by both programs as well as state funds are Kentucky, Greater California, Utah, Louisiana, Georgia, Iowa, New York, Massachusetts, Idaho, Illinois, and New Jersey. The TCR currently meets the NPCR high quality data standards, and is Gold Certified by the North American Association of Central Cancer Registries (NAACCR). The TCR joined the SEER program in 2021. The purpose and ultimate goal of the TCR is to collect, maintain, and disseminate the highest quality cancer data that will contribute towards cancer prevention and control—improving diagnoses, treatment, survival, and quality of life for all cancer patients. | Quick LinksReporter Updates
Report Web Plus Issues Timely Reporting Calendars How TCR Data Are Used (.pdf)
Updated August 2022 Recent Additions2022 Fall Texas Cancer Reporting Newsletter
October 2022 Female Breast Cancer in Texas Data Brief
October 2022
2022 Annual TCR Legislative Report
September 2022 TCR Newsletter Summer 2022 Edition
August 2022
|